AMO Corporation is a clinical research site located in Tallahassee, Florida, United States 32308.
Crixeo Clinical Trials Trust Score: 17/100 (FAILING). This profile has not yet been claimed by the site owner.
AMO Corporation has participated in 8 clinical trials with 2 currently active.
Therapeutic areas: Multiple Sclerosis, Relapsing Multiple Sclerosis, Partial Onset Seizures.
Sponsors: Novartis, Novartis Pharmaceuticals, Eisai Inc..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Florida · View every site in Tallahassee
Trust Score: 17/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
AMO Corporation has a Crixeo Trust Score of 17/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
AMO Corporation has 8 clinical trials on record, with 2 currently active. Their work covers Multiple Sclerosis, Relapsing Multiple Sclerosis, Partial Onset Seizures.
AMO Corporation has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.